‌

US Patent 11359025 Anti-IL1-RAP antibodies

Patent 11359025 was granted and assigned to Cantargia on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jagath R. Junutula0

Leonard G. Presta0

Ying Ping Jiang0

Date of Patent

June 14, 2022

0

Patent Application Number

163421760

Date Filed

October 16, 2017

0

Patent Citations

US Patent 10005841 Method of treating a solid tumor with IL1RAP antibodies

US Patent 10100119 Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer

US Patent 10287357 Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies

US Patent 10562971 Method of detection of IL1RAP on cells expressing the protein

US Patent 10005842 Method of treatment for leukemia using an anti-IL1RAP antibody

Patent Primary Examiner

0

Provided herein are antibodies specific for Interleukin-1 receptor accessory protein (IL1-RAP).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11359025 Anti-IL1-RAP antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.